Lori Capone

Title: Lori Capone: Innovator in Autoimmune and Inflammatory Disease Treatments

Introduction

Lori Capone is a notable inventor based in Edison, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment and management of autoimmune and inflammatory diseases. Her innovative work has led to the development of effective therapeutic methods that are crucial for patients suffering from various conditions.

Latest Patents

Lori Capone holds a patent for "Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases." This patent outlines methods for treating, preventing, or managing autoimmune inflammatory diseases and disorders, including but not limited to spondylitis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, and rheumatoid arthritis. The invention involves the administration of phosphodiesterase 4 (PDE4) inhibitors in combination with other therapeutics. Additionally, the patent discloses pharmaceutical compositions, dosage forms, and kits suitable for use in these methods.

Career Highlights

Lori Capone is associated with Celgene Corporation, where she has been instrumental in advancing research and development in her field. Her work has not only contributed to scientific knowledge but has also had a direct impact on patient care and treatment options.

Collaborations

Lori has collaborated with esteemed colleagues such as Peter Henry Schafer and Anita Gandhi. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in the treatment of autoimmune and inflammatory diseases.

Conclusion

Lori Capone's contributions to the field of medicine through her innovative patent work exemplify her dedication to improving patient outcomes. Her research continues to pave the way for new therapeutic approaches in managing complex diseases.